Matthew Hendricks
Psychiatric/Mental Health · Greenville, SCNPI 1821638404
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.3% of the total across 335 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 22.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,427 and has fallen 99.4% since, to $15 in 2025. Among psychiatric/mental health clinicians in SC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 335 payments — averaging $16.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Otsuka America Pharmaceutical, Inc.$539
- Sunovion Pharmaceuticals Inc.$535
- Takeda Pharmaceuticals U.S.A., Inc.$486
- Axsome Therapeutics, Inc.$426
- Vanda Pharmaceuticals Inc.$379
- plus $2K from 18 others
What the payments were for
- Food & beverage$5,30798%
- Education$922%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 99 | $1,208 |
| Otsuka America Pharmaceutical, Inc. | 33 | $539 |
| Sunovion Pharmaceuticals Inc. | 27 | $535 |
| Takeda Pharmaceuticals U.S.A., Inc. | 35 | $486 |
| Axsome Therapeutics, Inc. | 14 | $426 |
| Vanda Pharmaceuticals Inc. | 18 | $379 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 20 | $335 |
| Alkermes, Inc. | 19 | $332 |
| Neurocrine Biosciences, Inc. | 13 | $211 |
| Lundbeck LLC | 11 | $194 |
| Johnson & Johnson | 5 | $144 |
| Teva Pharmaceuticals USA, Inc. | 9 | $139 |
| Avanir Pharmaceuticals, Inc. | 8 | $126 |
| Bausch Health US, LLC | 7 | $100 |
| Gilead | 3 | $46 |
| Merck | 3 | $41 |
| Corium, LLC | 2 | $30 |
| Eisai Inc. | 2 | $29 |
| Almatica Pharma LLC | 2 | $29 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| Neos Therapeutics, LP | 1 | $13 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
| Adlon Therapeutics L.p. | 1 | $13 |
| Aytu Biopharma, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auvelity$124
How this compares
$5,399 in reported general payments places this provider in the 90th percentile of 354 psychiatric/mental health providers in South Carolina.
See all psychiatric/mental health providers in South Carolina →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 11 | $164 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Greenville
- Steven KrozerGreenville$139K
- Luron FlemingGreenville$61K
- Lauren DyerGreenville$16K
- Melissa BrownGreenville$16K
- William HendricksGreenville$13K
- Carrie BallengerGreenville$11K
- Gregory SmithGreenville$9K
- Svetlana RobinsonGreenville$8K
- Jared CarboneGreenville$7K
- Anglique RichGreenville$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.